Literature DB >> 22647861

Novel ANKH amino terminus mutation (Pro5Ser) associated with early-onset calcium pyrophosphate disease with associated phosphaturia.

Barry L Gruber1, Ana Rita Couto, Jácome Bruges Armas, Matthew A Brown, Kathleen Finzel, Robert A Terkeltaub.   

Abstract

This report describes a 32-year-old woman presenting since childhood with progressive calcium pyrophosphate disease (CPPD), characterized by severe arthropathy and chondrocalcinosis involving multiple peripheral joints and intervertebral disks. Because ANKH mutations have been previously described in familial CPPD, the proband's DNA was assessed at this locus by direct sequencing of promoter and coding regions and revealed 3 sequence variants in ANKH. Sequences of exon 1 revealed a novel isolated nonsynonymous mutation (c.13 C>T), altering amino acid in codon 5 from proline to serine (CCG>TCG). Sequencing of parental DNA revealed an identical mutation in the proband's father but not the mother. Subsequent clinical evaluation demonstrated extensive chondrocalcinosis and degenerative arthropathy in the proband's father. In summary, we report a novel mutation, not previously described, in ANKH exon 1, wherein serine replaces proline, in a case of early-onset severe CPPD associated with metabolic abnormalities, with similar findings in the proband's father.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22647861      PMCID: PMC4362680          DOI: 10.1097/RHU.0b013e3182582c3d

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  15 in total

1.  It ANKH necessarily so.

Authors:  Michael T Collins; Manfred Boehm
Journal:  J Clin Endocrinol Metab       Date:  2011-01       Impact factor: 5.958

2.  Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate.

Authors:  Yun Zhang; Kristen Johnson; R Graham G Russell; B Paul Wordsworth; Andrew J Carr; Robert A Terkeltaub; Matthew A Brown
Journal:  Arthritis Rheum       Date:  2005-04

3.  Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.

Authors:  L J Andrew; V Brancolini; L S de la Pena; M Devoto; F Caeiro; R Marchegiani; A Reginato; A Gaucher; P Netter; P Gillet; D Loeuille; D J Prockop; A Carr; B F Wordsworth; M Lathrop; S Butcher; E Considine; K Everts; A Nicod; S Walsh; C J Williams
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

4.  Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.

Authors:  Charlene J Williams; Yun Zhang; Andrew Timms; Gina Bonavita; Francisco Caeiro; John Broxholme; Jonathan Cuthbertson; Yvonne Jones; Raul Marchegiani; Antonio Reginato; R Graham G Russell; B Paul Wordsworth; Andrew J Carr; Matthew A Brown
Journal:  Am J Hum Genet       Date:  2002-09-17       Impact factor: 11.025

5.  Autosomal recessive mental retardation, deafness, ankylosis, and mild hypophosphatemia associated with a novel ANKH mutation in a consanguineous family.

Authors:  Eva Morava; Jirko Kühnisch; Jefte M Drijvers; Joris H Robben; Cor Cremers; Petra van Setten; Amanda Branten; Sabine Stumpp; Alphons de Jong; Krysta Voesenek; Sascha Vermeer; Angelien Heister; Hedi L Claahsen-van der Grinten; Charles W O'Neill; Michèl A Willemsen; Dirk Lefeber; Peter M T Deen; Uwe Kornak; Hannie Kremer; Ron A Wevers
Journal:  J Clin Endocrinol Metab       Date:  2010-10-13       Impact factor: 5.958

6.  Anthropometric and bone-related biochemical factors are associated with different haplotypes of ANKH locus.

Authors:  Michael Korostishevsky; Yulia Vistoropsky; Ida Malkin; Eugene Kobyliansky; Gregory Livshits
Journal:  Ann Hum Biol       Date:  2008 Sep-Oct       Impact factor: 1.533

7.  Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles.

Authors:  C Thouverey; G Bechkoff; S Pikula; R Buchet
Journal:  Osteoarthritis Cartilage       Date:  2008-07-07       Impact factor: 6.576

8.  Inhibition of calcium pyrophosphate dihydrate crystal formation: effects of carboxylate ions.

Authors:  P T Cheng; K P Pritzker
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

9.  P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells.

Authors:  Raihana Zaka; David Stokes; Arnold S Dion; Anna Kusnierz; Fei Han; Charlene J Williams
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) affects tissue non-specific Alkaline Phosphatase (TNAP) activities.

Authors:  John Wang; Hing Wo Tsui; Frank Beier; Kenneth P H Pritzker; Robert D Inman; Florence W L Tsui
Journal:  Open Rheumatol J       Date:  2008-04-10
View more
  3 in total

Review 1.  The Role of ANK in Calcium Pyrophosphate Deposition Disease.

Authors:  Elizabeth Mitton-Fitzgerald; Claudia M Gohr; Brittany Bettendorf; Ann K Rosenthal
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

2.  Combined approach for finding susceptibility genes in DISH/chondrocalcinosis families: whole-genome-wide linkage and IBS/IBD studies.

Authors:  Ana Rita Couto; Bruna Parreira; Russell Thomson; Marta Soares; Deborah M Power; Jim Stankovich; Jácome Bruges Armas; Matthew A Brown
Journal:  Hum Genome Var       Date:  2017-11-02

3.  The role of TNFRSF11B in development of osteoarthritic cartilage.

Authors:  Alejandro Rodríguez Ruiz; Margo Tuerlings; Ankita Das; Rodrigo Coutinho de Almeida; H Eka D Suchiman; Rob G H H Nelissen; Yolande F M Ramos; Ingrid Meulenbelt
Journal:  Rheumatology (Oxford)       Date:  2022-02-02       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.